Taipei Exchange - Delayed Quote TWD

BIONET TX Corp (7808.TWO)

Compare
46.00
-0.15
(-0.33%)
At close: January 22 at 2:58:57 PM GMT+8
Currency in TWD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
Total Revenue
43,329.00
5,369.00
--
Cost of Revenue
39,954.00
3,571.00
--
Gross Profit
3,375.00
1,798.00
--
Operating Expense
63,981.00
41,056.00
7,312.00
Operating Income
-60,606.00
-39,258.00
-7,312.00
Net Non Operating Interest Income Expense
5,967.00
1,892.00
11.00
Pretax Income
-54,310.00
-37,338.00
-7,301.00
Net Income Common Stockholders
-54,310.00
-37,338.00
-7,301.00
Diluted NI Available to Com Stockholders
-54,310.00
-37,338.00
-7,301.00
Basic EPS
-0.71
-2.47
-6.67
Diluted EPS
-0.71
-2.47
-6.67
Basic Average Shares
37,108.59
15,116.60
1,094.60
Diluted Average Shares
49,585.25
15,116.60
1,094.60
Total Expenses
103,935.00
44,627.00
7,312.00
Net Income from Continuing & Discontinued Operation
-54,310.00
-37,338.00
-7,301.00
Normalized Income
-54,304.00
-37,338.00
-7,301.00
Interest Income
5,967.00
1,892.00
11.00
Net Interest Income
5,967.00
1,892.00
11.00
EBIT
-60,606.00
-39,258.00
-7,312.00
EBITDA
-59,072.00
-38,676.00
-7,312.00
Reconciled Cost of Revenue
39,954.00
3,571.00
--
Reconciled Depreciation
1,534.00
582.00
--
Net Income from Continuing Operation Net Minority Interest
-54,310.00
-37,338.00
-7,301.00
Total Unusual Items Excluding Goodwill
-6.00
--
--
Total Unusual Items
-6.00
--
--
Normalized EBITDA
-59,066.00
-38,676.00
-7,312.00
12/31/2022 - 12/12/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Waiting for permission
Allow microphone access to enable voice search

Try again.